Yaupon Therapeutics, Inc. Submits New Drug Application for Proprietary Gel Formulation of Mechlorethamine Hydrochloride
Read more here


First-In-Class Novel Anti-Cancer Agent In Development By Niiki Pharma Shows Promising Phase I Results
Read more here


Infrascanner™ Software Designer Wins the Design of Medical Devices Top Award
Read more here


Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer
Read more here


Jeffrey Cummings, Rachelle Doody, Martin Farlow and Mary Sano to Form QR Pharma’s Medical Advisory Board
Read more here